日韩欧美 a级,国产又色又爽又刺激在线观看,偷偷色噜狠狠狠狠的777米奇,浮妇高潮喷白浆视频

SGX-523

    99%

SGX-523

源葉(MedMol)
S80027
1022150-57-7
C18H13N7S
359.42
6-(6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylthio)quinoline
品牌 貨號 產(chǎn)品規(guī)格 價(jià)格(RMB) 庫存(上海) 北京 武漢 南京 購買數(shù)量
源葉(MedMol) S80027-1mg 99% ¥112.00元 9 - - -
源葉(MedMol) S80027-5mg 99% ¥192.00元 5 - - -
源葉(MedMol) S80027-10mg 99% ¥360.00元 4 - - -
源葉(MedMol) S80027-25mg 99% ¥784.00元 7 - - -
源葉(MedMol) S80027-50mg 99% ¥1440.00元 5 - - -
源葉(MedMol) S80027-100mg 99% ¥2400.00元 預(yù)計(jì)交期:2-3天 - - -
產(chǎn)品介紹 參考文獻(xiàn) 質(zhì)檢證書(COA) 摩爾濃度計(jì)算器 相關(guān)產(chǎn)品

產(chǎn)品介紹

SGX523 is a exquisitely selective and ATP-competitive MET inhibitor. SGX523 potently inhibits MET with an IC50 of 4 nM and is >1,000-fold selective versus other protein kinases. Antitumor activity
產(chǎn)品描述: SGX523 is a exquisitely selective and ATP-competitive MET inhibitor. SGX523 potently inhibits MET with an IC50 of 4 nM and is >1,000-fold selective versus other protein kinases. Antitumor activity
靶點(diǎn): c-Met/HGFR;Raf;p38MAPK;c-Met/HGFR;Bcr-Abl
體內(nèi)研究: SGX523 exhibits antitumor activity in vivo. SGX523 inhibits MET-dependent tumor growth
參考文獻(xiàn): 1. Buchanan SG, et al. SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo. Mol Cancer Ther, 2009, 8(12), 3181-3190.
溶解性: DMSO  :  30  mg/mL  (83.47  mM;  Need  ultrasonic)
保存條件: -20℃
配置溶液濃度參考:
1mg 5mg 10mg
1 mM 2.782 ml 13.911 ml 27.823 ml
5 mM 0.556 ml 2.782 ml 5.565 ml
10 mM 0.278 ml 1.391 ml 2.782 ml
50 mM 0.056 ml 0.278 ml 0.556 ml
注意: 部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。

參考文獻(xiàn)

質(zhì)檢證書(COA)

如何獲取質(zhì)檢證書(COA)?
請輸入貨號和一個與之匹配的批號。
例如:
批號:JS298415 貨號:S20001-25g
在貨品標(biāo)簽上如何找到貨號和批號?

摩爾濃度計(jì)算器

質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

=
×
×

相關(guān)產(chǎn)品